IRIS Accounts Production v24.3.0.553 05855573 Board of Directors 1.1.23 31.3.24 31.3.24 true false true false false false true false 89837 352279 696123 702442 470000 440000 136286 89837 89837 352279 696123 702442 470000 440000 136286 89837 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh058555732022-12-31058555732024-03-31058555732023-01-012024-03-31058555732021-12-31058555732022-01-012022-12-31058555732022-12-3105855573ns15:EnglandWales2023-01-012024-03-3105855573ns14:PoundSterling2023-01-012024-03-3105855573ns10:Director12023-01-012024-03-3105855573ns10:PrivateLimitedCompanyLtd2023-01-012024-03-3105855573ns10:SmallEntities2023-01-012024-03-3105855573ns10:AuditExempt-NoAccountantsReport2023-01-012024-03-3105855573ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012024-03-3105855573ns10:SmallCompaniesRegimeForAccounts2023-01-012024-03-3105855573ns10:AbridgedAccounts2023-01-012024-03-310585557312023-01-012024-03-310585557341ns10:Director12022-12-310585557341ns10:Director12021-12-310585557341ns10:Director12023-01-012024-03-310585557341ns10:Director12022-01-012022-12-310585557341ns10:Director12024-03-310585557341ns10:Director12022-12-3105855573ns10:Director22023-01-012024-03-3105855573ns10:RegisteredOffice2023-01-012024-03-3105855573ns5:CurrentFinancialInstruments2024-03-3105855573ns5:CurrentFinancialInstruments2022-12-3105855573ns5:Non-currentFinancialInstruments2024-03-3105855573ns5:Non-currentFinancialInstruments2022-12-3105855573ns5:ShareCapital2024-03-3105855573ns5:ShareCapital2022-12-3105855573ns5:RetainedEarningsAccumulatedLosses2024-03-3105855573ns5:RetainedEarningsAccumulatedLosses2022-12-3105855573ns5:NetGoodwill2023-01-012024-03-3105855573ns5:IntangibleAssetsOtherThanGoodwill2023-01-012024-03-3105855573ns5:LandBuildings2023-01-012024-03-3105855573ns5:PlantMachinery2023-01-012024-03-3105855573ns5:Secured2024-03-3105855573ns5:Secured2022-12-3105855573ns10:Director222022-12-3105855573ns10:Director222021-12-3105855573ns10:Director222023-01-012024-03-3105855573ns10:Director222022-01-012022-12-3105855573ns10:Director222024-03-3105855573ns10:Director222022-12-31
REGISTERED NUMBER: 05855573 (England and Wales)















Community Therapeutic Services Limited

Unaudited Financial Statements

for the Period 1 January 2023 to 31 March 2024






Community Therapeutic Services Limited (Registered number: 05855573)






Contents of the Financial Statements
for the Period 1 January 2023 to 31 March 2024




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 4


Community Therapeutic Services Limited

Company Information
for the Period 1 January 2023 to 31 March 2024







DIRECTORS: Dr D Bladon-Wing
Dr E M M Bladon-Wing



REGISTERED OFFICE: 81 High Street
Worle
WESTON-SUPER-MARE
North Somerset
BS22 6ET



REGISTERED NUMBER: 05855573 (England and Wales)



ACCOUNTANTS: Maxwells
Chartered Accountants
4 King Square
Bridgwater
Somerset
TA6 3YF



BANKERS: National Westminster Bank plc
89 High Street
Weston-super-Mare
Somerset
BS23 1JW

Community Therapeutic Services Limited (Registered number: 05855573)

Abridged Statement of Financial Position
31 March 2024

31.3.24 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 5 - -
Tangible assets 6 1,813,017 1,767,725
Investments 7 299,283 1,000
2,112,300 1,768,725

CURRENT ASSETS
Debtors 1,999,060 1,804,541
Cash at bank and in hand 514,456 80,141
2,513,516 1,884,682
CREDITORS
Amounts falling due within one year 935,041 708,355
NET CURRENT ASSETS 1,578,475 1,176,327
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,690,775

2,945,052

CREDITORS
Amounts falling due after more than one year 8 (354,885 ) (273,696 )

PROVISIONS FOR LIABILITIES (63,965 ) (49,744 )
NET ASSETS 3,271,925 2,621,612

CAPITAL AND RESERVES
Called up share capital 2,000 282,000
Retained earnings 3,269,925 2,339,612
SHAREHOLDERS' FUNDS 3,271,925 2,621,612

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Community Therapeutic Services Limited (Registered number: 05855573)

Abridged Statement of Financial Position - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the period ended 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 September 2024 and were signed on its behalf by:





Dr E M M Bladon-Wing - Director


Community Therapeutic Services Limited (Registered number: 05855573)

Notes to the Financial Statements
for the Period 1 January 2023 to 31 March 2024

1. STATUTORY INFORMATION

Community Therapeutic Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2006, was amortised evenly over its estimated useful life of two years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Land and buildings - 2% on cost
Plant and machinery etc - 50% on cost, 33% on cost, 25% on cost and 25% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Community Therapeutic Services Limited (Registered number: 05855573)

Notes to the Financial Statements - continued
for the Period 1 January 2023 to 31 March 2024

3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 137 (2022 - 118 ) .

5. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2023
and 31 March 2024 80,000
AMORTISATION
At 1 January 2023
and 31 March 2024 80,000
NET BOOK VALUE

At 31 March 2024 -
At 31 December 2022 -

Community Therapeutic Services Limited (Registered number: 05855573)

Notes to the Financial Statements - continued
for the Period 1 January 2023 to 31 March 2024

6. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2023 2,706,724
Additions 208,473
Grants (9,843 )
At 31 March 2024 2,905,354
DEPRECIATION
At 1 January 2023 938,999
Charge for period 153,338
At 31 March 2024 1,092,337
NET BOOK VALUE
At 31 March 2024 1,813,017
At 31 December 2022 1,767,725

Included in cost of land and buildings is freehold land of £ 34,000 (2022 - £ 34,000 ) which is not depreciated.

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Totals
£   
COST
At 1 January 2023
and 31 March 2024 31,555
DEPRECIATION
At 1 January 2023 7,889
Charge for period 7,396
At 31 March 2024 15,285
NET BOOK VALUE
At 31 March 2024 16,270
At 31 December 2022 23,666

Community Therapeutic Services Limited (Registered number: 05855573)

Notes to the Financial Statements - continued
for the Period 1 January 2023 to 31 March 2024

7. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
At 1 January 2023 1,000
Disposals (1,000 )
At 31 March 2024 -
NET BOOK VALUE
At 31 March 2024 -
At 31 December 2022 1,000

Investments (neither listed nor unlisted) were as follows:
31.3.24 31.12.22
£    £   
Other investments - additions 300,000 -
Other investments - impairment (717 ) -
299,283 -

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE
YEARS
31.3.24 31.12.22
£    £   
Repayable by instalments
Bank loans 125,480 116,956

9. SECURED DEBTS

The following secured debts are included within creditors:

31.3.24 31.12.22
£    £   
Bank loans 377,697 502,713
Hire purchase contracts 23,134 31,598
400,831 534,311

Bank loans and overdrafts are secured by a debenture and a legal charge over the property and its associated assets. The directors have also given a guarantee for £50,000.

Hire purchase agreements are secured over the asset to which they relate.

Community Therapeutic Services Limited (Registered number: 05855573)

Notes to the Financial Statements - continued
for the Period 1 January 2023 to 31 March 2024

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 31 March 2024 and the year ended 31 December 2022:

31.3.24 31.12.22
£    £   
Dr D Bladon-Wing and Dr E M M Bladon-Wing
Balance outstanding at start of period (89,837 ) (352,279 )
Amounts advanced 696,123 702,442
Amounts repaid (470,000 ) (440,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period 136,286 (89,837 )

11. ULTIMATE CONTROLLING PARTY

The company is under the joint control of its directors, D Bladon-Wing and E M M Bladon-Wing, who together, own all of the company's issued share capital.